PRESS RELEASE published on 10/04/2023 at 21:30, 2 years 2 months ago EQS-Adhoc: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C
PRESS RELEASE published on 09/27/2023 at 18:30, 2 years 2 months ago European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023
PRESS RELEASE published on 09/20/2023 at 12:30, 2 years 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants
PRESS RELEASE published on 08/07/2023 at 19:00, 2 years 3 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination
PRESS RELEASE published on 06/27/2023 at 12:55, 2 years 5 months ago General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions
PRESS RELEASE published on 06/26/2023 at 19:15, 2 years 5 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting
PRESS RELEASE published on 06/23/2023 at 19:30, 2 years 5 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. received redemption notices with respect to EUR 185.85 million – minimum net cash condition is not yet fulfilled
PRESS RELEASE published on 06/21/2023 at 09:43, 2 years 5 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information
PRESS RELEASE published on 05/16/2023 at 23:15, 2 years 6 months ago European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH
PRESS RELEASE published on 05/16/2023 at 00:45, 2 years 6 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants
Published on 12/05/2025 at 02:35, 7 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 20 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 31 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 55 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour 16 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
